Science
Mechanism of Action
AKBA primarily exerts its anti-inflammatory effects by selectively inhibiting the 5-lipoxygenase (5-LOX) enzyme through a non-redox, noncompetitive mechanism, thereby reducing the synthesis of pro-inflammatory leukotrienes and, to a lesser extent, prostaglandins. It also mitigates the production of various pro-inflammatory cytokines such as IL-1, IL-2, IL-6, IFN-γ, and TNF-α, and inhibits nuclear transcription factor KappaB (NF-κB) signaling. Additionally, AKBA demonstrates inhibitory activity against collagenase and elastase, enzymes implicated in skin degradation.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
AKBA-capped nanoparticles exhibit maximum stability (peak intensity) within a pH range of 6.0 to 7.0, with aggregation observed at very low and high pH conditions. Due to its low water solubility, AKBA is sparingly soluble in aqueous buffers; for maximal aqueous solubility, it should first be dissolved in an organic solvent (e.g., DMSO) and then diluted. Aqueous solutions are not recommended for storage for more than one day.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not specifically reviewed Acetyl Beta-Boswellic Acid. However, the gum resin from Boswellia, its botanical source, is Generally Recognized As Safe (GRAS) by the US FDA. AKBA itself has been reported to be safe, exhibiting minimal toxicity on human skin cells and classified as 'Not Classified' under GHS hazard criteria.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Acetyl Beta-Boswellic Acid is a valuable anti-inflammatory and antioxidant ingredient, highly compatible with all skin types and well-tolerated, making it suitable for sensitive and compromised skin.
Related
Similar Ingredients
Finding similar ingredients…